Uncategorised - European Medical Journal

Pharma review of the year 2024

Look back at the key moments from the past year in pharma with three of our former guests, as they highlight key trends, challenges and more.

Real-World Raynaud’s Management in Systemic Sclerosis

Raynaud’s phenomenon (RP) in systemic sclerosis (SSc) can lead to chronic digital ischemia, ulcerations, and necrosis with significant…

The latest edition of AMJ Rheumatology

What’s the future of rheumatology? Discover it in AMJ’s latest journal. From how AI is revolutionizing care to the year’s most impactful…

Review of the American College of Rheumatology (ACR) Convergence 2024

SET against the vibrant backdrop of Washington, D.C., this year’s American College of Rheumatology (ACR) Convergence was truly…

Current Applications and Future Roles of AI in Rheumatology

AI is the process of simulation of human intelligence by computer systems. These processes encompass learning, reasoning, and…

Rheumatology’s Most Impactful Discoveries This Year

EXPERTS at the American College of Rheumatology (ACR) Convergence 2024 identified and showcased the most groundbreaking discoveries in the…

AI Tool Predicts Early Flare in Rheumatic Diseases

Rheumatic and musculoskeletal diseases (RMD) affect up to one-third of the UK population, are the number one cause of disability, and are…

Harnessing the Power of AI in Rheumatology

THIS year’s American College of Rheumatology (ACR) Convergence, which took place from Novemeber 14th–19th 2024 in Washington, D.C., saw…

Plant-Based Diet Impact on Gout: A Pilot Study

An unhealthy diet is an important modifiable risk factor for hyperuricemia and gout and is also associated with obesity and metabolic…

Boosting Prior Authorization with AI in Rheumatology

The prior authorization (PA) process in healthcare, while necessary for ensuring the medical necessity and cost-effectiveness of treatments, often results in significant delays. This study explores the potential of AI